We further proved that impairment of ERK1/2 pathways by inhibitor U0126 resulted in similar effects (decreased growth, migration and invasion of HCC cells) such as those induced by PBLD overexpression in vitro (Supplementary Figure 4). The gene discussed is PBLD; the disease is hepatocellular carcinoma.